Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts von Griffiths, Elizabeth A, Golding, Michelle C, Srivastava, Pragya, Povinelli, Benjamin J, James, Smitha R, Ford, Laurie A, Wetzler, Meir, Wang, Eunice S, Nemeth, Michael J

Volltext

Is obesity a prognostic factor for acute myeloid leukemia outcome? von Lee, Hun Ju, Licht, Andrea S., Hyland, Andrew J., Ford, Laurie A., Sait, Sheila N. J., Block, AnneMarie W., Barcos, Maurice, Baer, Maria R., Wang, Eunice S., Wetzler, Meir

Volltext

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia von Emadi, Ashkan, Faramand, Rawan, Carter‐Cooper, Brandon, Tolu, Seda, Ford, Laurie A., Lapidus, Rena G., Wetzler, Meir, Wang, Eunice S., Etemadi, Arash, Griffiths, Elizabeth A.

Volltext

Concordance of Pharmacogenetic Polymorphisms in Tumor and Germ Line DNA in Adult Patients with Acute Myeloid Leukemia von WEISS, Joli R, BAER, Maria R, AMBROSONE, Christine B, BLANCO, Javier G, HUTSON, Alan, FORD, Laurie A, MOYSICH, Kirsten B

Volltext

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old von Gupta, Neha, Miller, Austin, Gandhi, Shipra, Ford, Laurie A., Vigil, Carlos E., Griffiths, Elizabeth A., Thompson, James E., Wetzler, Meir, Wang, Eunice S.

Volltext

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia von Lee, Hun Ju, Muindi, Josephia R., Tan, Wei, Hu, Qiang, Wang, Dan, Liu, Song, Wilding, Gregory E., Ford, Laurie A., Sait, Sheila N. J., Block, Annemarie W., Adjei, Araba A., Barcos, Maurice, Griffiths, Elizabeth A., Thompson, James E, Wang, Eunice S., Johnson, Candace S., Trump, Donald L., Wetzler, Meir

Volltext

Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature von Ustwani, Omar Al, Ford, Laurie A, Sait, Sheila J.N, Block, Anne Marie W, Barcos, Maurice, Vigil, Carlos E, Griffiths, Elizabeth A, Thompson, James E, Wang, Eunice S, Ambrus, Julian, Wetzler, Meir

Volltext

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia von Muppidi, Monica R, Portwood, Scott, Griffiths, Elizabeth A, Thompson, James E, Ford, Laurie A, Freyer, Craig W, Wetzler, Meir, Wang, Eunice S

Volltext

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia von Wetzler, Meir, Thomas, Debora A, Wang, Eunice S, Shepard, Robert, Ford, Laurie A, Heffner, Thompson L, Parekh, Samir, Andreeff, Michael, O'Brien, Susan, Kantarjian, Hagop M

Volltext

Smoking adversely affects survival in acute myeloid leukemia patients von Varadarajan, Ramya, Licht, Andrea S., Hyland, Andrew J., Ford, Laurie A., Sait, Sheila N.J., Block, Annemarie W., Barcos, Maurice, Baer, Maria R., Wang, Eunice S., Wetzler, Meir

Volltext

Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival von Benekli, Mustafa, Xia, Zheng, Donohue, Kathleen A., Ford, Laurie A., Pixley, Lynda A., Baer, Maria R., Baumann, Heinz, Wetzler, Meir

Volltext

A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia von Griffiths, Elizabeth A, Brady, William E, Tan, Wei, Vigil, Carlos E, Thompson, James E, Ford, Laurie A, Dickey, Noelle M, Bashaw, Heather, Sperrazza, Jill, Wetzler, Meir, Wang, Eunice S

Volltext

Phase 1 study of arsenic trioxide, high‐dose cytarabine, and idarubicin to down‐regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <... von Wetzler, Meir, Andrews, Chris, Ford, Laurie A., Tighe, Sheila, Barcos, Maurice, Sait, Sheila N. J., Block, AnneMarie W., Nowak, Norma J., Baer, Maria R., Wang, Eunice S., Baumann, Heinz

Volltext

Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function von Brady, Michael T, Miller, Austin, Sait, Sheila N, Ford, Laurie A, Minderman, Hans, Wang, Eunice S, Lee, Kelvin P, Baumann, Heinz, Wetzler, Meir

Volltext

Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases von Noor, Syed J, Tan, Wei, Wilding, Gregory E, Ford, Laurie A, Barcos, Maurice, Sait, Sheila N.J, Block, AnneMarie W, Thompson, James E, Wang, Eunice S, Wetzler, Meir

Volltext

Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age von Vigil, Carlos E, Tan, Wei, Deeb, George, Sait, Sheila N, Block, Annemarie W, Starostik, Petr, Griffiths, Elizabeth A, Thompson, James E, Greene, Jessica D, Ford, Laurie A, Wang, Eunice S, Wetzler, Meir

Volltext

Decitabine and sorafenib therapy in FLT3-ITD mutant acute myeloid leukemia- A case series von Muppidi, Monica R, Griffiths, Elizabeth A, Thompson, James E, Ford, Laurie A, Freyer, Craig W, Wetzler, Meir, Wang, Eunice S

Volltext

Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival von Suvannasankha, Attaya, Minderman, Hans, O'Loughlin, Kieran L., Nakanishi, Takeo, Ford, Laurie A., Greco, William R., Wetzler, Meir, Ross, Douglas D., Baer, Maria R.

Volltext

Heterogeneous effects of targeting WNT signaling in AML blasts von Srivastava, Pragya, Griffiths, Elizabeth A, Golding, Michelle C, Povinelli, Benjamin J, James, Smitha R, Ford, Laurie A, Wetzler, Meir, Wang, Eunice S, Nemeth, Michael J

Volltext

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: Possible role of cytarabine von Arana-Yi, Cecilia, Block, AnneMarie W, Sait, Sheila N, Ford, Laurie A, Barcos, Maurice, Baer, Maria R

Volltext